-Ritedose is the development partner and manufacturer of Ohtuvayre (ensifentrine)*, the first inhaled product with a novel mechanism of action in more than 20 years for the maintenance treatment of ...

"Physicians should feel more confident in following the recent guideline recommendations both to use race-neutral reference equations and to use z scores for assessing severity…Together, these changes ...

Check this table to make sure you can use your COPD inhalers together Medically reviewed by Sanja Jelic, MD Most people with chronic obstructive pulmonary disease (COPD) use an inhaler every day to ...

Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases Through this acquisition Merck will add ...

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)-- Aptar Digital Health, part of Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announced a strategic ...

Discover how machine learning is helping researchers identify different groups of chronic obstructive pulmonary disease (COPD ...

RAHWAY, N.J. & RALEIGH, N.C., July 09, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Verona Pharma plc (Nasdaq: VRNA) ("Verona Pharma"), a ...